Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J).

An association between week 12 PASI improvement and Itch NRS (0) responses at week 12 was evident, with a clear trend toward increasing improvement in Itch NRS (0) with increasing levels of improvement in PASI (Fig. 2 c).

also in 19,460 other papers